___

• 1. Global Burden of Disease Cancer Collaboration. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016:A Systematic Analysis for the Global Burden of Disease Study. JAMAOncology June 2,2018. doi:10.1001/jamaoncol. 2018.2706. 2. Gultekin M, Dundar S, Kucukyildiz I, Karaca MZ, Boztas G, Turan SH, et al. Survival of gynecological cancers in Turkey: where are we at?J Gynecol Oncol. 2017;28(6):e85. 3. Pınar I, Algıer L, Doğan N, Kaya N. Determination of the Risk Factors in Individuals with Gynecological Cancer. Int J Hematol Oncol Stem Cell Res. 2008;(4):208-16. 4. Lyngea E, Lönnbergb S, Törnberg S. Cervical cancer incidence in elderly women-biology or screening history?Eur J Cancer. 2017;(74):82-8. 5. Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, et al. Human papillomavirus–associated cancers-United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2016;65(26):661-6. 6. Purdie DM, and GreenAC.Best Pract Res Clin Obstet Gynaecol;15(3):341-54. 7. Kheiri SA, Kunna A, Babiker AY, Alsuhaibani SA, Ahmed RY, Alsammani MA. Histopathological Pattern and Age Distribution of Malignant Ovarian Tumor among Sudanese Ladies. Maced J Med Sci. 2018;12;6(2):237-41. 8. Adegoke O,. KulasingamS, and VirnigB. Cervical cancer trends in the United States: a 35‐year population‐based analysis. J. Womens Health. 2012;(21):1031–7. 9. Eifel PJ, BurkeTW, MorrisM, and SmithTL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol. Oncol1995;(59):38–44. 10. Bray FB, Carstensen H, Møller H, ZappaM, ZakeljMP, LawrenceG, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol. Biomarkers Prev. 2005;(14):2191-9.